VTVT
vTv Therapeutics Inc
NASDAQ: VTVT · HEALTHCARE · BIOTECHNOLOGY
$32.24
+3.10% today
Updated 2026-04-30
Market cap
$125.92M
P/E ratio
—
P/S ratio
14,852.65x
EPS (TTM)
$-3.20
Dividend yield
—
52W range
$14 – $44
Volume
0.1M
vTv Therapeutics Inc (VTVT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $976000.00 | $1.55M | $519000.00 | $634000.00 | $291000.00 | $12.43M | $2.76M | $6.41M | $4.00M | $2.02M | $9000.00 | $1.02M | $0.00 |
| Revenue growth (YoY) | — | +58.7% | -66.5% | +22.2% | -54.1% | +4172.9% | -77.8% | +132.1% | -37.6% | -49.6% | -99.6% | +11200.0% | -100.0% |
| Cost of revenue | $25.43M | $18.73M | $29.58M | $45.75M | $39.64M | $23.04M | $15.12M | $11.02M | $89000.00 | $92000.00 | $90000.00 | $89000.00 | $16000.00 |
| Gross profit | $-24.46M | $-17.18M | $519000.00 | $-45.11M | $-39.35M | $-10.60M | $-12.36M | $-4.60M | $4.00M | $2.02M | $-90000.00 | $1.02M | $-16000.00 |
| Gross margin | -2505.9% | -1109.1% | 100.0% | -7115.8% | -13522.0% | -85.3% | -447.0% | -71.7% | 100.0% | 100.0% | -1000.0% | 100.0% | — |
| R&D | $25.43M | $18.73M | $29.58M | $45.75M | $39.64M | $23.04M | $15.12M | $11.02M | $13.32M | $12.36M | $13.60M | $11.55M | $17.86M |
| SG&A | $11.38M | $11.72M | $9.08M | $9.91M | $11.33M | $9.22M | $8.54M | $7.25M | $12.34M | $12.20M | $11.91M | $13.65M | $14.95M |
| Operating income | $-35.83M | $-28.90M | $-38.14M | $-55.02M | $-50.68M | $-19.82M | $-20.89M | $-11.85M | $-21.66M | $-22.54M | $-25.50M | $-24.18M | $-32.81M |
| Operating margin | -3671.4% | -1865.5% | -7349.1% | -8678.2% | -17416.5% | -159.4% | -755.9% | -184.8% | -540.9% | -1116.9% | -283355.6% | -2377.6% | — |
| EBITDA | $-35.30M | $-29.23M | $-37.64M | $-54.69M | $-50.56M | $-20.14M | $-19.97M | $-12.02M | $-17.52M | $-24.77M | $-25.86M | $-22.52M | $-32.79M |
| EBITDA margin | -3616.3% | -1886.9% | -7252.6% | -8626.2% | -17373.9% | -162.0% | -722.6% | -187.3% | -437.3% | -1227.3% | -287366.7% | -2214.0% | — |
| EBIT | $-36.38M | $-30.09M | $-38.14M | $-54.95M | $-50.76M | $-20.36M | $-20.01M | $-12.11M | $-17.60M | $-24.86M | $-25.95M | $-22.61M | $-32.81M |
| Interest expense | $11.82M | $6.01M | $1.74M | $398000.00 | $3.09M | $3.29M | $1.83M | $692000.00 | $12000.00 | $15000.00 | $13000.00 | $0.00 | $6000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-48.20M | $-36.10M | $-27.50M | $-16.35M | $-16.14M | $-7.91M | $-21.94M | $-8.50M | $-12.99M | $-19.16M | $-20.25M | $-18.46M | $-26.97M |
| Net income growth (YoY) | — | +25.1% | +23.8% | +40.5% | +1.3% | +51.0% | -177.3% | +61.3% | -52.8% | -47.6% | -5.7% | +8.8% | -46.1% |
| Profit margin | -4938.8% | -2330.6% | -5298.3% | -2579.2% | -5547.8% | -63.6% | -793.7% | -132.5% | -324.3% | -949.7% | -225000.0% | -1815.3% | — |